The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Open accessAbstract
Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of copper and copper triggered cell death in the pathogenesis of cancers have attracted attentions. Cuproptosis has garnered enormous interest in cancer research communities because of its great potential for cancer therapy. Copper-based treatment exerts an inhibiting role in tumor growth and may open the door for the treatment of chemotherapy-insensitive tumors. In this review, we provide a critical analysis on copper homeostasis and the role of copper dysregulation in the development and progression of cancers. Then the core molecular mechanisms of cuproptosis and its role in cancer is discussed, followed by summarizing the current understanding of copper-based agents (copper chelators, copper ionophores, and copper complexes-based dynamic therapy) for cancer treatment. Additionally, we summarize the emerging data on copper complexes-based agents and copper ionophores to subdue tumor chemotherapy resistance in different types of cancers. We also review the small-molecule compounds and nanoparticles (NPs) that may kill cancer cells by inducing cuproptosis, which will shed new light on the development of anticancer drugs through inducing cuproptosis in the future. Finally, the important concepts and pressing questions of cuproptosis in future research that should be focused on were discussed. This review article suggests that targeting cuproptosis could be a novel antitumor therapy and treatment strategy to overcome cancer drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–333 of 333
Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
Fu, S., Naing, A., Fu, C., Kuo, M. T., & Kurzrock, R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0864 · Cited by 90
Teoh-Fitzgerald, M. L. T., Fitzgerald, M. P., Jensen, T. J., Futscher, B. W., & Domann, F. E. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0501 · Cited by 90
Wang, Y., An, L., Lin, J., Tian, Q., & Yang, S. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123925 · Cited by 90
Self-citationATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle
Horn, N., & Wittung-Stafshede, P. E. (2021) · Biomedicines · doi:10.3390/biomedicines9040391 · Cited by 90
Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
Zheng, L., Long, Y., Tsai, W.-B., Fu, S., Kurzrock, R., Gagea-Iurascu, M., Zhang, F., Chen, H. H. W., Hennessy, B. T., Mills, G. B., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0580 · Cited by 88
Li, S., Zhang, J., Yang, H., Wu, C., Dang, X., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep12410 · Cited by 88
Self-citationDissecting metastasis using preclinical models and methods
Hebert, J. D., Neal, J. W., & Winslow, M. M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00568-4 · Cited by 86
Copper-dependent amino oxidase 3 governs selection of metabolic fuels in adipocytes
Yang, H., Ralle, M., Wolfgang, M. J., Dhawan, N., Burkhead, J. L., Rodriguez, S., Kaplan, J. H., Wong, G. W., Haughey, N. J., & Lutsenko, S. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006519 · Cited by 85
Wang, Q., Niu, D., Shi, J., & Wang, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01006 · Cited by 83
Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy
Luca, A. D., Barile, A., Arciello, M., & Rossi, L. C. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.06.008 · Cited by 82
Clearable Black Phosphorus Nanoconjugate for Targeted Cancer Phototheranostics
Jana, D., Jia, S., Bindra, A. K., Xing, P., Ding, D., & Zhao, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02718 · Cited by 82
Huang, X. Y., Hou, Y., Weng, X., Pang, W., Hou, L., Liang, Y., Wang, Y., Du, L., Wu, T., Yao, M., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00295-7 · Cited by 80
Self-citationO’Leary, B. R., Fath, M. A., Bellizzi, A. M., Hrabe, J. E., Button, A. M., Allen, B. G., Case, A. J., Altekruse, S. F., Wagner, B. A., Buettner, G. R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1959 · Cited by 78
Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1
Qiu, L., Ding, X., Zhang, Z., & Kang, Y. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194662 · Cited by 77
Copper enhances genotoxic drug resistance via ATOX1 activated DNA damage repair
Jin, J., Ma, M., Shi, S., Wang, J., Xiao, P., Yu, H., Zhang, C., Guo, Q., Yu, Z., Lou, Z., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215651 · Cited by 77
Self-citationGupte, A., & Mumper, R. J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.003 · Cited by 76
The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
Liu, Z., Ma, H., & Lai, Z. (2023) · Molecules · doi:10.3390/molecules28041623 · Cited by 76
Yang, Z., Zhao, Z., Cheng, H., Shen, Y., Xie, A., & Zhu, M. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.03.065 · Cited by 76
Identification of COX17 as a therapeutic target for non-small cell lung cancer.
Suzuki, C., Daigo, Y., Kikuchi, T., Katagiri, T., & Nakamura, Y. (2003) · PubMed · Cited by 75
Wangpaichitr, M., Wu, C., You, M., Maher, J. C., Dinh, V., Feun, L. G., & Savaraj, N. (2009) · Cancers · doi:10.3390/cancers1010023 · Cited by 75
Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors
Gandin, V., Ceresa, C., Esposito, G., Indraccolo, S., Porchia, M., Tisato, F., Santini, C., Pellei, M., & Marzano, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-13698-1 · Cited by 74
Jiang, M., Zhang, Z., Li, W., Man, X., Sun, H., Liang, H., & Yang, F. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00698 · Cited by 73
Wadhwa, S., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.027 · Cited by 72
Marttila‐Ichihara, F., Auvinen, K., Elima, K., Jalkanen, S., & Salmi, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1205 · Cited by 71
Slator, C., Molphy, Z. E., McKee, V., Long, C., Brown, T., & Kellett, A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky105 · Cited by 71
Zhang, W. K., Shi, H., Chen, C., Ren, K., Xu, Y., Liu, X., & He, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.058 · Cited by 71
Cater, M. A., & Haupt, Y. (2011) · Biochemical Journal · doi:10.1042/bj20110123 · Cited by 70
Cao, R., Sun, W. C., Zhang, Z., Li, X., Du, J., Fan, J., & Peng, X. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.06.031 · Cited by 70
Angiogenesis and Metabolism: Entwined for Therapy Resistance
Jiménez-Valerio, G., & Casanovas, O. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.11.007 · Cited by 68
Suska, F., Esposito, M. A., Gretzer, C., Källtorp, M., Tengvall, P., & Thomsen, P. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00359-9 · Cited by 68
Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Furukawa, T., Komatsu, M., Ikeda, R., Tsujikawa, K., & Akiyama, S. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848479 · Cited by 68
Copper chaperone Atox1 plays role in breast cancer cell migration
Blockhuys, S., & Wittung-Stafshede, P. E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.148 · Cited by 68
Wang, N., Wang, L., Li, Y., Fu, S.-Y., Xue, X., Jia, L.-N., Yuan, X., Wang, Y., Tang, X., Yang, J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.004 · Cited by 68
Self-citationGomez-Jenkins, M., Shah, N., Kenny, T. C., Jenkins, E. C., & Germain, D. (2019) · Oncogene · doi:10.1038/s41388-019-0839-x · Cited by 67
Zhang, J., Han, M., Zhang, J., Abdalla, M., Sun, P., Yang, Z., Zhang, C., Liu, Y., Chen, C., & Jiang, X. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123025 · Cited by 67
Self-citationExtracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?
Laukkanen, M. O. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3612589 · Cited by 66
Molecular Imaging-Guided Sonodynamic Therapy
Guo, J., Pan, X., Wang, C., & Liu, H. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00288 · Cited by 66
Kita, Y., Hamada, A., Saito, R., Teramoto, Y., Tanaka, R., Takano, K., Nakayama, K., Murakami, K., Matsumoto, K., Akamatsu, S., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0609-0 · Cited by 65
Bormio Nunes, J. H., Hager, S., Mathuber, M., Pósa, V., Roller, A., Enyedy, E. A., Stefanelli, A., Berger, W., Keppler, B. K., Heffeter, P., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01277 · Cited by 65
Adeoti, M., Oguntola, A., Akanni, E., et al. (2015) · Indian Journal of Cancer · doi:10.4103/0019-509x.175573 · Cited by 64
Xu, M., Casio, M., Range, D. E., Sosa, J. A., & Counter, C. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3705 · Cited by 64
Ji, Y., Dai, F., & Zhou, B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.017 · Cited by 64
Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway
He, F., Chang, C., Liu, B., Li, Z., Li, H., Cai, N., & Wang, H. (2019) · BioMed Research International · doi:10.1155/2019/4158415 · Cited by 64
Self-citationDisrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-Renewal
Singh, R. P., Jeyaraju, D. V., Voisin, V., Hurren, R., Xu, C., Hawley, J. R., Barghout, S. H., Khan, D. H., Gronda, M., Wang, X., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.04.010 · Cited by 64
Multifunctional Cu2−xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453
Poulose, A. C., Veeranarayanan, S., Mohamed, M. S., Aburto, R. R., Mitcham, T., Bouchard, R. R., Ajayan, P. M., Sakamoto, Y., Maekawa, T., & Kumar, D. S. (2016) · Scientific Reports · doi:10.1038/srep35961 · Cited by 63
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram
Cong, J., Wang, Y., Zhang, X., Zhang, N., Liu, L., Soukup, K., Michelakos, T. P., Hong, T. S., DeLeo, A. B., Cai, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.028 · Cited by 63
Self-citationGlutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy
Chen, M., Huang, Z., Xia, M., Ding, Y., Shan, T., Guan, Z., Dai, X., Xu, X., Huang, Y., Huang, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.041 · Cited by 63
Dou, L., Lu, E., Tian, D., Li, F., Deng, L., & Zhang, Y. (2023) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0091 · Cited by 63
Garg, M. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.6 · Cited by 62
Copper in the tumor microenvironment and tumor metastasis
Kamiya, T. (2022) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-9 · Cited by 62
Zhang, X., Walke, G. R., Horváth, I., Kumar, R., Blockhuys, S., Holgersson, S., Walton, P. H., & Wittung-Stafshede, P. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206905119 · Cited by 62
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
Kang, X., Jadhav, S., Annaji, M., Huang, C.-H., Amin, R., Shen, J., Ashby, C. R., Tiwari, A. K., Babu, R. J., & Chen, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061567 · Cited by 62
Jin, Y., Zhang, C., Xu, H., Shaoli, X., Wang, Y., Hou, Y., Kong, Y., & Xu, Y. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.06.004 · Cited by 61
Self-citationYu, Z., Cao, W., Ren, Y., Zhang, Q., & Liu, J. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.19 · Cited by 61
An NIR-triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates
Zhang, L., Li, Y., Jin, Z., Yu, J. C., & Chan, K. M. (2015) · Nanoscale · doi:10.1039/c5nr02767e · Cited by 60
Self-citationBista, R., Lee, D. W., Pepper, O. B., Azorsa, D. O., Arceci, R. J., & Aleem, E. A. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0493-5 · Cited by 57
Cierlitza, M., Chauvistré, H., Bogeski, I., Zhang, X., Hauschild, A., Herlyn, M., Schadendorf, D., VOGT, T. M., & Roesch, A. (2014) · Experimental Dermatology · doi:10.1111/exd.12613 · Cited by 56
Nie, X., Chen, H., Xiong, Y., Chen, J., & Liu, T. (2022) · Journal of Cancer · doi:10.7150/jca.77445 · Cited by 53
Self-citationKim, Y., Tsang, T., Anderson, G. R., Posimo, J. M., & Brady, D. C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1784 · Cited by 51
Lee, S. Y., Seo, J., Kim, S., Hwang, C., Jeong, D. I., Park, J., Yang, M., Huh, J. W., & Cho, H. (2023) · Small · doi:10.1002/smll.202301402 · Cited by 51
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer
Blockhuys, S., Brady, D. C., & Wittung-Stafshede, P. E. (2020) · Breast Cancer · doi:10.1007/s12282-019-01044-4 · Cited by 50
Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231
Chu, M., An, X., Fu, C., Yu, H., Zhang, D., Li, Q., Man, X., Dai, X., & Li, Z. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808186 · Cited by 50
Groleau, J., Dussault, S., Haddad, P., Turgeon, J., Ménard, C., Chan, J. S. D., & Rivard, A. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.212530 · Cited by 49
Nie, D., Chen, C., Li, Y., & Zeng, C. (2022) · Blood Science · doi:10.1097/bs9.0000000000000117 · Cited by 48
Self-citationCopper Chelation as an Antiangiogenic Therapy
Lowndes, S. A., & Harris, A. L. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040042707952 · Cited by 47
Copper activates TrkB in cortical neurons in a metalloproteinase‐dependent manner
Hwang, J. J., Park, M., & Koh, J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21350 · Cited by 46
Nakao, S., Noda, K., Zandi, S., Sun, D., Taher, M., Schering, A., Xie, F., Mashima, Y., & Hafezi‐Moghadam, A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.011 · Cited by 46
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy
Xu, J., Brosseau, J., & Shi, H. (2020) · Oncogene · doi:10.1038/s41388-020-01491-w · Cited by 46
Cheriyan, V. T., Wang, Y., Muthu, M., Jamal, S., Chen, D., Yang, H., Polin, L., Tarca, A. L., Pass, H. I., Dou, Q. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093711 · Cited by 45
Self-citationPhotodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals
Veeranarayanan, S., Mohamed, M. S., Poulose, A. C., Rinya, M., Sakamoto, Y., Maekawa, T., & Kumar, D. S. (2018) · Theranostics · doi:10.7150/thno.25286 · Cited by 44
Wu, L., Meng, F., Dong, L., Block, C. J., Mitchell, A. V., Wu, J. H., Jang, H., Chen, W., Polin, L., Yang, Q., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35619-6 · Cited by 44
Feng, Q., Zhang, W., Li, Y., Yang, X., Hao, Y., Zhang, H., Li, W., Hou, L., & Zhang, Z. (2017) · Nanoscale · doi:10.1039/c7nr05003h · Cited by 43
Self-citationThe Effectiveness and Safety of X-PDT for Cutaneous Squamous Cell Carcinoma and Melanoma
Shi, L., Liu, P., Wu, J., Ma, L., Zheng, H., Antosh, M. P., Zhang, H., Wang, B., Chen, W., & Wang, X. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0094 · Cited by 43
Jiang, W., Su, L., Ao, M., Guo, X., Chen, C., Luo, Y., Xie, Z., Wang, X., Wang, J., Liu, S., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00947-9 · Cited by 43
Self-citationDinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents
Massoud, S. S., Louka, F. R. Y., Salem, N. M. H., Fischer, R. C., Torvisco, A., Mautner, F. A., Vančo, J., Belza, J., Dvořák, Z., & Trávníček, Z. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114992 · Cited by 43
Wehbe, M., Lo, C., Leung, A. W. Y., Dragowska, W. H., Ryan, G. M., & Bally, M. B. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0488-2 · Cited by 42
Falls-Hubert, K. C., Butler, A. L., Gui, K., Anderson, M., Li, M., Stolwijk, J. M., Rodman, S. N., Solst, S. R., Tomanek‐Chalkley, A., Searby, C. C., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.186 · Cited by 42
Modulating undruggable targets to overcome cancer therapy resistance
Passirani, C., Vessières, A., Regina, G. L., Link, W., & Silvestri, R. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100788 · Cited by 41
Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
Yoo, J. Y., Pradarelli, J. C., Haseley, A., Wojton, J., Kaka, A. S., Bratasz, A., Alvarez-Breckenridge, C. A., Yu, J.-G., Powell, K. A., Mazar, A. P., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0697 · Cited by 40
Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy
Lan, Q.-H., Du, C.-C., Yu, R.-J., Zhai, J., Shi, Y., Kou, L., Xiao, J., Lu, C., Zhao, Y., & Yao, Q. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120978 · Cited by 40
Qiao, S., Cabello, C. M., Lamore, S. D., Lesson, J. L., & Wondrak, G. T. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0746-x · Cited by 39
Harrington, B. S., Ozaki, M. K., Caminear, M. W., Hernandez, L. F., Jordan, E., Kalinowski, N. J., Goldlust, I. S., Guha, R., Ferrer, M., Thomas, C. J., et al. (2020) · Cancers · doi:10.3390/cancers12061645 · Cited by 38
Jang, B., Xu, L., Santhamoorthy, M., Zhang, W., Zeng, L., Kang, M., Kwak, M., Oh, J., & Jin, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22331 · Cited by 37
Cao, Y., Jin, L., Zhang, S., Lv, Z., Yin, N., Zhang, H., Zhang, T., Wang, Y., Chen, Y., Liu, X., et al. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106319 · Cited by 37
Self-citationMeng, X., Zhang, X., Lei, Y., Cao, D., & Wang, Z. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02476g · Cited by 36
Zhang, S., Dong, Y. J., Chen, X., Tan, C. S. H., Li, M., Miao, K., & Lu, J. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00605-8 · Cited by 36
Wu, L., Zhou, L., Liu, D. Q., Vogt, F. G., & Kord, A. S. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.09.007 · Cited by 33
Lv, J., Wang, S., Qiao, D., Lin, Y., Hu, S., & Li, M. C. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01244-9 · Cited by 33
Kang, X., Wang, J., Huang, C.-H., Wibowo, F. S., Amin, R., Chen, P., & Li, F. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102620 · Cited by 33
Self-citationNanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors
Sun, W., Chu, C., Li, S., Ma, X., Liu, P., Chen, S., & Chen, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114643 · Cited by 33
Maor, I., Asadi, S., Korganbayev, S., Dahis, D., Shamay, Y., Schena, E., Azhari, H., Saccomandi, P., & Weitz, I. S. (2021) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2021.1883406 · Cited by 32
Mariani, D., Ghasemishahrestani, Z., de Freitas, W. R., et al. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129963 · Cited by 32
Garza, N. M., Zulkifli, M., & Gohil, V. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102139 · Cited by 32
Zhang, X., Jiang, Q., Su, Y., Bu, L., Sun, Z., Wu, X., Gao, B. X., Wang, L., Lin, Y., Xie, W., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02127-4 · Cited by 32
Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway
Ren, Y., Lin, Y., Chen, J., & Jin, Y. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00466 · Cited by 30
Self-citationCopper(II)-disulfiram loaded melanin-dots for cancer theranostics
Shi, H., Suo, Y., Zhang, Z., Liu, R., Liu, H., & Cheng, Z. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102340 · Cited by 29
Suliman, A. S., Khoder, M., Tolaymat, I., Webster, M., Alany, R. G., Wang, W., Elhissi, A. M. A., & Najlah, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010084 · Cited by 28
Jiang, Y., Liu, Y., Wang, M., Li, Z., Su, L., Xu, X., Xing, C., Li, J., Lin, L., Lü, C., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c20898 · Cited by 27
Challenges and Chances in the Preclinical to Clinical Translation of Anticancer Metallodrugs
Poetsch, I., Baier, D., Keppler, B. K., & Berger, W. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016452-00308 · Cited by 26
Fan, K., Dong, Y., Li, T., & Li, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1036408 · Cited by 26
Self-citationKhan, S., Zafar, A., & Naseem, I. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103818 · Cited by 25
Ackermann, C. J., Adderley, H., Franco, A. O., Khan, A. M., Reck, M., & Califano, R. (2020) · Drugs · doi:10.1007/s40265-020-01409-6 · Cited by 25
Ji, H. B., Kim, C. R., Min, C. H., Han, J. H., Kim, S., Lee, C., & Choy, Y. B. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10477 · Cited by 25
Lin, Q., Hou, S., Dai, Y., Jiang, N., & Lin, Y. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001467 · Cited by 24
A novel copper chelator for the suppression of colorectal cancer
Shi, X., Li, Y., Jia, M., Zhang, Z., Huang, L., Zhang, M., Xun, Q., Jiang, D., & Liu, Y. (2023) · Drug Development Research · doi:10.1002/ddr.22034 · Cited by 24
Self-citationKaterji, M., Barada, K. A., Jomaa, M., Kobeissy, F. H., Makkawi, A.-K., Abou-Kheir, W. G., & Usta, J. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00010 · Cited by 23
Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy
Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202213922 · Cited by 23
Zhang, S., Zong, Y., Chen, L., Li, Q., Li, Z., & Meng, R. (2023) · Discover Oncology · doi:10.1007/s12672-023-00729-9 · Cited by 23
Hayashi, M., NISHIYA, H., CHIBA, T., Endoh, D., Kon, Y., & Okui, T. (2007) · Journal of Veterinary Medical Science · doi:10.1292/jvms.69.137 · Cited by 22
Hassan, I., Khan, A. A., Aman, S., Qamar, W., Ebaid, H., Al‐Tamimi, J., Alhazza, I. M., & Rady, A. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19410-1 · Cited by 22
Liu, H., Kong, Y., Liu, Z., Guo, X., Yang, B., Yin, T., He, H., Gou, J., Zhang, Y. X., & Tang, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121788 · Cited by 22
Zhang, C., Men, D., Zhang, T., Yu, Y., Xiang, J., Jiang, G., & Hang, L. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20677 · Cited by 21
Abu-Serie, M. M., & Abdelfattah, E. Z. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-30553-8 · Cited by 21
Hartwig, F., Köll-Weber, M., & Süss, R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060894 · Cited by 20
COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis
Hancock, J. L., Kalimutho, M., Straube, J., Lim, M., Gresshoff, I. L., Saunus, J. M., Lee, J. S., Lakhani, S. R., Simpson, K. J., Bush, A. I., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02663-8 · Cited by 20
Ning, S., Mo, J., Huang, R., Liu, B., Fu, B., Ding, S., Yang, H., Cui, Y., & Yao, L. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1191014 · Cited by 20
Cao, H.-Z., Yang, W., & Zheng, P. (2022) · BMC Cancer · doi:10.1186/s12885-022-09574-5 · Cited by 19
Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?
Fatma, H., & Siddique, H. R. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666221107113648 · Cited by 19
Zhang, Y., Qi, G., Qu, X., Wang, B., Ma, K., & Jin, Y. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c03256 · Cited by 18
He, L., Xu, F., Li, Y., Jin, H., & Lo, P. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.020 · Cited by 18
Self-citationZafar, A., Singh, S., Ahmad, S., Khan, S., Siddiqi, M. I., & Naseem, I. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.031 · Cited by 17
Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
Hendrych, M., Říhová, K., Adamová, B., Hradil, V., Stiborek, M., Vlček, P., Hermanová, M., Vašíčková, J., Beneš, P., Šmarda, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113465 · Cited by 17
Barresi, V., Spampinato, G., Musso, N., Salinaro, A. T., Rizzarelli, E., & Condorelli, D. F. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.01.002 · Cited by 15
Yu, N., Zhu, H., Yang, Y.-A., Tao, Y., Tan, F., Pei, Q., Zhou, Y., Song, X., Tan, Q., & Pei, H. (2017) · Oncotarget · doi:10.18632/oncotarget.17807 · Cited by 15
Self-citationLi, N., Yuan, W., Jianyong, Y., & Huang, Y. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220907115027 · Cited by 15
Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma
Li, X., Wang, Q., Xu, C., Zhang, L., Zhou, J., Lv, J., Xu, M., & Jiang, D. (2023) · Cancers · doi:10.3390/cancers15041301 · Cited by 15
Wang, X., Hu, A., Du, K., & Feng, F. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00915 · Cited by 14
Hassan, I., Ebaid, H., Alhazza, I. M., Al‐Tamimi, J., & Rady, A. M. (2023) · Pharmaceuticals · doi:10.3390/ph16020169 · Cited by 11
Prus, E., Peled, T., & Fibach, E. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001598035 · Cited by 10
Li, Z., Xie, X., Tan, G., Xie, F., Liu, N., Li, W., & Sun, X. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00353 · Cited by 8
Poly(methacrylate citric acid) as a Dual Functional Carrier for Tumor Therapy
Yu, B., Shen, Y., Zhang, X., Ding, L., Meng, Z., Wang, X., Han, M., Guo, Y., & Wang, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091765 · Cited by 8
Copper (α)/ cis -platinum-loaded nanogels as an adjuvant potentiate disulfiram's antitumor efficacy
Geng, Y., Sun, R., Zhang, Y., Zhou, Z., & Shen, Y. (2022) · Biomaterials Science · doi:10.1039/d1bm01795k · Cited by 6
Wang, Q., Ye, J., Wang, J., Liu, M., Li, C., Lv, W., Liu, S., Niu, N., Xu, J., & Fu, Y. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00626j · Cited by 6
Self-citation
Cited by
Liu, Y., Zhang, X., Chen, X., & Zhang, F. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2025.123621 · Cited by 20
Metadata
- Authors
- Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 72
- Pages
- 101018
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4388600670
- Cited by
- 256
- References
- 333
- FWCI
- 37.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.